Development of an innovative platform & bdn; COMBITOX & rdning; for the toxicological diagnosis of drug addiction, use and alcohol (Q77756): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Removed claim: summary (P836): The WHO’s dependence is considered to be one of the most important diseases of civilisation.Alcohol is followed by a growing number of younger people.The ease with which new compounds with psychoactive properties are placed on the market and the widespread use of more and more medicines for older people make the phenomenon of dependency for each age group easier.The identification of a group of persons at risk of addiction, monitoring of treat...)
(‎Created claim: summary (P836): Addiction according to WHO is considered to be one of the most important diseases of civilisation. Alcohol is used by younger and younger people. The ease of placing new compounds with psychoactive properties on the market and the prevalence of increasing use of drugs in older people mean that addiction affects each age group. Identifying a group of people at risk of addiction, monitoring of rehab patients and proper diagnosis of poisoned people...)
Property / summary
 
Addiction according to WHO is considered to be one of the most important diseases of civilisation. Alcohol is used by younger and younger people. The ease of placing new compounds with psychoactive properties on the market and the prevalence of increasing use of drugs in older people mean that addiction affects each age group. Identifying a group of people at risk of addiction, monitoring of rehab patients and proper diagnosis of poisoned people is a problem requiring a comprehensive solution. The aim of the project will be industrial research and development work aimed at creating an innovative, comprehensive platform (COMBITOX) to diagnose patients who are addicted to alcohol, drugs, drugs, boosters or those at risk of such dependence (e.g. young people). The project’s objective will be achieved through the implementation of specific tasks leading to the development of the key components of the platform (ALCOTOX and NARCOTOX), which will include, inter alia: Identification of alcohol markers and validation of methods of identification; Designing an innovative method of sample preparation for toxicological tests; Innovative use of advanced instrumental techniques for the determination of psychoactive substances and medicines; Developing a method to verify available toxicological diagnostic tools; Preparation of an algorithm to identify and report newly detected boosters to the EMCDDA. The method, the creation of which is the essence of the project, is characterised by a high application potential. Target groups will be addiction treatment centres, toxicological units, sores, sanitary inspectorates, penitentiary units and courts, prosecutors, police units and border guards. Applicants’ experience has identified areas for improvement available (English)
Property / summary: Addiction according to WHO is considered to be one of the most important diseases of civilisation. Alcohol is used by younger and younger people. The ease of placing new compounds with psychoactive properties on the market and the prevalence of increasing use of drugs in older people mean that addiction affects each age group. Identifying a group of people at risk of addiction, monitoring of rehab patients and proper diagnosis of poisoned people is a problem requiring a comprehensive solution. The aim of the project will be industrial research and development work aimed at creating an innovative, comprehensive platform (COMBITOX) to diagnose patients who are addicted to alcohol, drugs, drugs, boosters or those at risk of such dependence (e.g. young people). The project’s objective will be achieved through the implementation of specific tasks leading to the development of the key components of the platform (ALCOTOX and NARCOTOX), which will include, inter alia: Identification of alcohol markers and validation of methods of identification; Designing an innovative method of sample preparation for toxicological tests; Innovative use of advanced instrumental techniques for the determination of psychoactive substances and medicines; Developing a method to verify available toxicological diagnostic tools; Preparation of an algorithm to identify and report newly detected boosters to the EMCDDA. The method, the creation of which is the essence of the project, is characterised by a high application potential. Target groups will be addiction treatment centres, toxicological units, sores, sanitary inspectorates, penitentiary units and courts, prosecutors, police units and border guards. Applicants’ experience has identified areas for improvement available (English) / rank
 
Normal rank
Property / summary: Addiction according to WHO is considered to be one of the most important diseases of civilisation. Alcohol is used by younger and younger people. The ease of placing new compounds with psychoactive properties on the market and the prevalence of increasing use of drugs in older people mean that addiction affects each age group. Identifying a group of people at risk of addiction, monitoring of rehab patients and proper diagnosis of poisoned people is a problem requiring a comprehensive solution. The aim of the project will be industrial research and development work aimed at creating an innovative, comprehensive platform (COMBITOX) to diagnose patients who are addicted to alcohol, drugs, drugs, boosters or those at risk of such dependence (e.g. young people). The project’s objective will be achieved through the implementation of specific tasks leading to the development of the key components of the platform (ALCOTOX and NARCOTOX), which will include, inter alia: Identification of alcohol markers and validation of methods of identification; Designing an innovative method of sample preparation for toxicological tests; Innovative use of advanced instrumental techniques for the determination of psychoactive substances and medicines; Developing a method to verify available toxicological diagnostic tools; Preparation of an algorithm to identify and report newly detected boosters to the EMCDDA. The method, the creation of which is the essence of the project, is characterised by a high application potential. Target groups will be addiction treatment centres, toxicological units, sores, sanitary inspectorates, penitentiary units and courts, prosecutors, police units and border guards. Applicants’ experience has identified areas for improvement available (English) / qualifier
 
point in time: 14 October 2020
Timestamp+2020-10-14T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Revision as of 10:16, 14 October 2020

Project in Poland financed by DG Regio
Language Label Description Also known as
English
Development of an innovative platform & bdn; COMBITOX & rdning; for the toxicological diagnosis of drug addiction, use and alcohol
Project in Poland financed by DG Regio

    Statements

    0 references
    5,685,065.35 zloty
    0 references
    1,364,415.68 Euro
    13 January 2020
    0 references
    7,205,019.39 zloty
    0 references
    1,729,204.65 Euro
    13 January 2020
    0 references
    78.9 percent
    0 references
    1 September 2018
    0 references
    31 August 2021
    0 references
    INSTYTUT EKSPERTYZ TOKSYKOLOGICZNYCH SP. Z O.O.
    0 references
    0 references

    51°7'34.7"N, 16°58'41.5"E
    0 references
    Uzależnienie wg WHO uważane jest za jedną z najważniejszych chorób cywilizacyjnych. Po alkohol sięgają coraz młodsze osoby. Łatwość wprowadzenia na rynek nowych związków o właściwościach psychoaktywnych i powszechność stosowania coraz większej ilości leków u ludzi starszych powodują, że zjawisko uzależnienia dotyczy każdej grupy wiekowej. Wytypowanie grupy osób zagrożonych uzależnieniem, monitorowanie pacjentów leczonych odwykowo i właściwa diagnostyka osób zatrutych są problemem wymagającym kompleksowego rozwiązania. Celem projektu będą badania przemysłowe i prace rozwojowe zmierzające do stworzenia nowatorskiej, kompleksowej platformy (COMBITOX) do diagnostyki pacjentów uzależnionych od alkoholu, narkotyków, leków, dopalaczy, bądź zagrożonych takim uzależnieniem (np. młodzieży). Cel projektu zostanie osiągnięty poprzez realizację zadań szczegółowych prowadzących do opracowania kluczowych komponentów platformy (ALCOTOX i NARCOTOX), które będą obejmować m.in.: Wytypowanie markerów alkoholizmu i walidacja metod ich oznaczania; Zaprojektowanie innowacyjnej metody przygotowania próbek do badań toksykologicznych; Innowacyjne wykorzystanie zaawansowanych technik instrumentalnych do oznaczania substancji psychoaktywnych i leków; Opracowanie metody umożliwiającej weryfikację dostępnych narzędzi diagnostyki toksykologicznej; Przygotowanie algorytmu identyfikacji i zgłaszania nowo wykrytych dopalaczy do EMCDDA. Metodę, której stworzenie stanowi istotę projektu, cechuje wysoki potencjał aplikacyjny. Grupami docelowymi będą ośrodki leczenia uzależnień, oddziały toksykologiczne, SORy, inspektoraty sanitarne, jednostki penitencjarne oraz sądy, prokuratury, jednostki policji i straży granicznej. Doświadczenie wnioskodawców pozwoliło zidentyfikować obszary wymagające ulepszenia dostępnyc (Polish)
    0 references
    Addiction according to WHO is considered to be one of the most important diseases of civilisation. Alcohol is used by younger and younger people. The ease of placing new compounds with psychoactive properties on the market and the prevalence of increasing use of drugs in older people mean that addiction affects each age group. Identifying a group of people at risk of addiction, monitoring of rehab patients and proper diagnosis of poisoned people is a problem requiring a comprehensive solution. The aim of the project will be industrial research and development work aimed at creating an innovative, comprehensive platform (COMBITOX) to diagnose patients who are addicted to alcohol, drugs, drugs, boosters or those at risk of such dependence (e.g. young people). The project’s objective will be achieved through the implementation of specific tasks leading to the development of the key components of the platform (ALCOTOX and NARCOTOX), which will include, inter alia: Identification of alcohol markers and validation of methods of identification; Designing an innovative method of sample preparation for toxicological tests; Innovative use of advanced instrumental techniques for the determination of psychoactive substances and medicines; Developing a method to verify available toxicological diagnostic tools; Preparation of an algorithm to identify and report newly detected boosters to the EMCDDA. The method, the creation of which is the essence of the project, is characterised by a high application potential. Target groups will be addiction treatment centres, toxicological units, sores, sanitary inspectorates, penitentiary units and courts, prosecutors, police units and border guards. Applicants’ experience has identified areas for improvement available (English)
    14 October 2020
    0 references

    Identifiers

    POIR.01.01.01-00-0175/18
    0 references